TARS Annual Retained Earnings
-$244.66 M
-$135.89 M-124.94%
31 December 2023
Summary:
As of January 23, 2025, TARS annual retained earnings is -$244.66 million, with the most recent change of -$135.89 million (-124.94%) on December 31, 2023. During the last 3 years, it has fallen by -$211.81 million (-644.88%). TARS annual retained earnings is now -17836.66% below its all-time high of -$1.36 million, reached on December 31, 2018.TARS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS Quarterly Retained Earnings
-$337.10 M
-$23.42 M-7.47%
30 September 2024
Summary:
As of January 23, 2025, TARS quarterly retained earnings is -$337.10 million, with the most recent change of -$23.42 million (-7.47%) on September 30, 2024. Over the past year, it has dropped by -$92.44 million (-37.78%). TARS quarterly retained earnings is now -5486.63% below its all-time high of -$6.03 million, reached on December 31, 2019.TARS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -124.9% | -37.8% |
| 3 y3 years | -644.9% | -37.8% |
| 5 y5 years | -10000.0% | -37.8% |
TARS Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -424.2% | at low | -622.3% | at low |
| 5 y | 5-year | -3954.6% | at low | -5486.6% | at low |
| alltime | all time | <-9999.0% | at low | -5486.6% | at low |
Tarsus Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$337.10 M(+7.5%) |
| June 2024 | - | -$313.68 M(+11.9%) |
| Mar 2024 | - | -$280.39 M(+14.6%) |
| Dec 2023 | -$244.66 M(+124.9%) | -$244.66 M(+20.7%) |
| Sept 2023 | - | -$202.75 M(+23.9%) |
| June 2023 | - | -$163.61 M(+23.8%) |
| Mar 2023 | - | -$132.18 M(+21.5%) |
| Dec 2022 | -$108.76 M | -$108.76 M(+14.3%) |
| Sept 2022 | - | -$95.16 M(+31.0%) |
| June 2022 | - | -$72.65 M(+8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$66.91 M(+43.4%) |
| Dec 2021 | -$46.67 M(+42.1%) | -$46.67 M(+46.7%) |
| Sept 2021 | - | -$31.82 M(+97.4%) |
| June 2021 | - | -$16.12 M(-28.2%) |
| Mar 2021 | - | -$22.47 M(-31.6%) |
| Dec 2020 | -$32.84 M(+444.3%) | -$32.84 M(+53.6%) |
| Sept 2020 | - | -$21.38 M(+90.2%) |
| June 2020 | - | -$11.24 M(+86.3%) |
| Dec 2019 | -$6.03 M(+342.4%) | -$6.03 M |
| Dec 2018 | -$1.36 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual retained earnings year-on-year change?
- What is Tarsus Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly retained earnings year-on-year change?
What is Tarsus Pharmaceuticals annual retained earnings?
The current annual retained earnings of TARS is -$244.66 M
What is the all time high annual retained earnings for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual retained earnings is -$1.36 M
What is Tarsus Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, TARS annual retained earnings has changed by -$135.89 M (-124.94%)
What is Tarsus Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of TARS is -$337.10 M
What is the all time high quarterly retained earnings for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly retained earnings is -$6.03 M
What is Tarsus Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, TARS quarterly retained earnings has changed by -$92.44 M (-37.78%)